Occudo Quantitative Strategies’s Axsome Therapeutics AXSM Stock Holding History

Occudo Quantitative Strategies’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.57M	Sell	10,490 -3,336	-24%	-$723K	0.14%	220
2026 Q1	$2.87M	Buy	+13,826	New	+$2.39M	0.16%	199
2023 Q4	–	Sell	-2,864	Closed	-$200K	–	803
2023 Q3	$200K	Buy	+2,864	New	+$214K	0.03%	800
2021 Q4	–	Sell	-37,505	Closed	-$1.24M	–	1061
2021 Q3	$1.24M	Buy	+37,505	New	+$1.46M	0.15%	203
2021 Q1	–	Sell	-3,971	Closed	-$324K	–	747
2020 Q4	$324K	Buy	+3,971	New	+$297K	0.1%	387

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Occudo Quantitative Strategies's AXSM Position: Q2 2026 in Review

Occudo Quantitative Strategies reduced its Axsome Therapeutics (AXSM) stake by 24% in Q2 2026, selling an estimated $723K and leaving 10,490 shares worth $2.57M. The position accounts for 0.14% of the portfolio, ranked #220.

Occudo Quantitative Strategies first reported a position in AXSM in Q4 2020 and has held it in 5 quarters since. The position peaked at $2.87M in Q1 2026. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Occudo Quantitative Strategies held 10,490 shares of Axsome Therapeutics worth $2.57M as of Q2 2026.
Occudo Quantitative Strategies sold 3,336 Axsome Therapeutics shares in Q2 2026, an estimated $723K.
Axsome Therapeutics made up 0.14% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #220 holding.
Occudo Quantitative Strategies first reported a position in Axsome Therapeutics in Q4 2020 and has held it in 5 quarters since.
Occudo Quantitative Strategies's Axsome Therapeutics position peaked at $2.87M in Q1 2026.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.